Lv32
270 积分 2025-03-06 加入
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
4小时前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
16小时前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
19天前
已完结
The race to reset autoimmune diseases
19天前
已完结
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
30天前
已完结
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
30天前
已完结
Bone marrow involvement in systemic lupus erythematosus
1个月前
已完结
Single-cell profiling reveals kidney CD163+dendritic cell participation in human lupus nephritis
1个月前
已完结
Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020
1个月前
已完结
Barriers to CAR T-cell therapy in rheumatology
1个月前
已完结
皖公网安备34019202002308
